Connect with us

Press Release

This One Company Is Working On A Breakthrough Approach To Revolutionize Pain Management

Published

on

–News Direct–

By Austin DeNoce, Benzinga

Autonomix Medical (NASDAQ: AMIX) is a medical device company dedicated to transforming the diagnosis and treatment of diseases or disorders related to the nervous system. At the core of Autonomix's innovative approach is a first-in-class technology platform featuring a catheter-based microchip sensing array. This technology boasts an unprecedented ability to detect and differentiate neural signals with up to 3,000 times greater sensitivity than existing technologies. This breakthrough has paved the way for transvascular diagnosis and treatment of nervous system diseases virtually anywhere in the body, offering a new horizon of medical possibilities and market opportunities.

Clinical Studies In Pancreatic Cancer Pain

Autonomix has initiated its first clinical study targeting pancreatic cancer pain, marking a significant milestone in its ongoing medical innovation. Pancreatic cancer represents a considerable unmet medical need, particularly concerning pain management. Effective solutions in this area are critically needed, as current relief options for pancreatic diseases are limited to drugs like opioids. In light of that, the initiation of these clinical studies represents a crucial step toward addressing this substantial healthcare challenge for suffering patients.

Market Opportunities

In addition to addressing the pain relief needs of patients, Autonomixs technology presents significant market opportunities across various medical fields. By accurately targeting the nervous system, Autonomix aims to address unmet needs and improve treatments for a wide range of conditions including but not limited to:

  • Pancreatic Cancer Pain: The successful application of Autonomix's technology in pancreatic cancer pain management would not only help pancreatic cancer patients find relief from pain but also unlocks significant market potential. Pancreatic cancer pain management is part of a $2.2 billion market for pancreatic cancer treatment.

  • Chronic Pain: This market presents a significant opportunity estimated at $75 billion. Conditions such as lower back pain, pelvic pain, urinary tract pain, digestive disorders and other tumor-related pain are prevalent and often inadequately managed with current therapies, particularly opioids. Autonomix's technology offers the potential to significantly reduce or eliminate the dependence on opioids, providing a safer and more effective solution for chronic pain management.

  • Cardiovascular Diseases: With a market opportunity estimated at $23 billion, Autonomix's technology could revolutionize the treatment of conditions like hypertension and cardiovascular disease. By targeting the nervous system's role in these diseases, more precise and effective treatments could be developed.

  • Pulmonary Diseases: Chronic obstructive pulmonary disease (COPD) is another area where Autonomix's technology could have a substantial impact. The market for COPD treatments is estimated to be around $18 billion with considerable growth ahead, driven by the need for more effective and less side-effect-prone therapies. Autonomix's approach could provide a new paradigm in managing this debilitating condition.

Meeting Unmet Needs with Innovative Solutions

Current drug therapies for many of these conditions often come with significant side effects and do not adequately address the underlying issues. Autonomix's technology offers a promising alternative by providing targeted, nerve-based treatments that could improve patient outcomes and quality of life. This innovative approach aligns with Autonomix's mission to dramatically enhance the lives of millions by enabling precise and effective nerve-targeted treatments. In doing so, Autonomix can both detect and ablate malfunctioning nerves in one simple procedure, effectively opening new treatment options in the field of electrophysiology.

The Full Opportunity

Autonomix Medical sits at the forefront of a potential revolution in medical treatment for diseases driven by the nervous system. The companys advanced technology platform not only offers hope for better management of pancreatic cancer pain, but also opens the door to addressing numerous other conditions with significant unmet need. By providing physicians with powerful new tools for diagnosis and treatment, Autonomix is poised to make a profound impact on the future of healthcare.

Featured photo by Irwan on Unsplash.

Autonomix is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated. The Companys first-in-class technology platform includes a catheter-based microchip sensing array that has the ability to detect and differentiate neural signals with approximately 3,000 times greater sensitivity than currently available technologies. We believe this will enable, for the first time ever, transvascular diagnosis and treatment of diseases involving the peripheral nervous system virtually anywhere in the body.We are initially developing our technology for pancreatic cancer pain, a condition that can cause debilitating pain and needs an effective solution. However, our technology constitutes a platform with the potential to address dozens of indications, including in cardiology, renal denervation and chronic pain management across a wide disease spectrum.

Some of the statements in this release are forward-looking statements, which involve risks and uncertainties. Forward-looking statements in this press release include, without limitation, the timing of the completion of patient enrollment in the trial and the Companys ability to successfully meet the milestones set forth in this press release on a timely basis, if at all. Such forward-looking statements can be identified by the use of words such as should, may, intends, anticipates, believes, estimates, projects, forecasts, expects, plans, and proposes.Although Autonomix Medical, Inc. (or Autonomix) believes that the expectations reflected in these forward-looking statements are based on reasonable assumptions, there are a number of risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading Risk Factors and elsewhere in the offering circular filed with the U.S. Securities and Exchange Commission (SEC) on January 26, 2024. Forward-looking statements speak only as of the date of the document in which they are contained and Autonomix does not undertake any duty to update any forward-looking statements except as may be required by law.

This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice.

Contact Details

JTC Team, LLC

autonomix@jtcir.com

Company Website

https://autonomix.com/

View source version on newsdirect.com: https://newsdirect.com/news/this-one-company-is-working-on-a-breakthrough-approach-to-revolutionize-pain-management-840932661

Autonomix Medical, Inc.

comtex tracking

COMTEX_453436019/2655/2024-06-06T09:04:53

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

WHY VANESSA HUDGENS CHOSE AMAZON’S EKOUAER OVER LUXURY LABELS — AND WHAT IT REVEALS ABOUT FASHION’S NEW ERA

Published

on

New York, US / Timesnewswire / October 2, 2026 – For decades, A-list celebrity endorsements followed a predictable blueprint: high fashion, multi-million-dollar haute couture deals, and unattainable luxury. But this fall, Hollywood star Vanessa Hudgens is continuing her game-changing fashion narrative with Amazon’s sleepwear and loungewear giant, EKOUAER.

First announced as an official EKOUAER Brand Friend earlier this July, Hudgens’ collaboration with the brand hits a major crescendo this October as EKOUAER celebrates its 11th Anniversary. Rather than aligned with exclusive runaway brands, Hudgens has embraced the ultimate daily wardrobe staple used by millions of everyday women across America.

“Becoming a mom has definitely made me appreciate versatility even more,” says Vanessa Hudgens. “I want pieces that are comfortable and easy for everyday life, but that I can dress up and still feel really good in.”

As EKOUAER marks its 11-year milestone, the timing coincides with October’s major Amazon shopping moment, proving that “everyday comfort” is officially beating traditional luxury status symbols. The star’s fall favorites spotlight pieces engineered for multi-scenario living, including the viral Ekouaer Satin Pajamas Set with Bow Tie Front and and the versatile, ultra-cozy Ekouaer 2-Piece Pleated Lounge & Sweater Set. “For me, it’s about finding that sweet spot where you feel comfortable but still put together,” Hudgens adds. “I love being able to take the same piece and completely change the feeling of it depending on how I style it.”

As EKOUAER kicks off its 11th Anniversary celebrations, the alliance redefines modern celebrity style: luxury isn’t about the price tag—it’s about effortless comfort.

EKOUAER

Dana Li

pr@EKOUAER.com

New York, US

https://EKOUAER.com/

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

From One Store to 400 Daily Orders: 70-Year-Old Lalit Kumar Takes Natural Spices Online Across UAE

Published

on

The Indian-born businessman has lived and worked in the UAE since 1983. Now 70, he has taken a single grocery store online, and it handles around 400 orders a day.

Dubai, Al Nahda 1, United Arab Emirates, 2nd Oct 2026 – When shipments were getting stuck and many small shops decided to sit tight, Lalit Kumar did the opposite. At 70, the owner of Natural Spices and Foodstuff Trading LLC moved his grocery business online. Today it delivers to customers in every emirate.

He started with one retail outlet and five staff. The business now handles about 400 orders a day through its own website, NaturalSpicesUAE.com, and through the UAE’s major online marketplaces. It sells spices, herbs, Indian groceries, snacks, dry fruits and other daily essentials.

Forty Years in the UAE

Mr. Kumar came to the UAE from India in 1983. Since then he has run businesses in electronics, transport, and oil and gas, and now in foodstuff. He says each one prepared him for the next. Electronics taught him how customers think. Transport taught him about timing. Oil and gas taught him patience.

“I came here as a young man and this country gave me a chance. It gave my family a home. I have never taken that for granted, and everything I build here is my way of saying thank you.”
— Lalit Kumar, Owner, Natural Spices and Foodstuff Trading LLC

Moving When Others Waited

The shift online came at a hard time for retail. Deliveries were running late, costs were going up and fewer people were walking into shops. Mr. Kumar decided not to wait it out.

With his team of five, he set up online ordering, reorganised the stock and worked out packing and delivery, all from the same store they were already running. The website went live, the products went onto the marketplaces, and orders started coming in from across the country.

“I have seen this market go up and down many times since 1983. If you stop every time things get difficult, you will never move. At my age people expect me to slow down. I would rather see what comes next.”
— Lalit Kumar

Still in the Store Every Day

Orders now go out to Abu Dhabi, Dubai, Sharjah, Ajman, Umm Al Quwain, Ras Al Khaimah and Fujairah. Customers say they come back for the range, the fair prices and delivery they can count on.

Growth hasn’t pulled Mr. Kumar away from the business. He is in the store every day. He talks to customers himself, bargains with suppliers and makes the big decisions. His staff say he has more energy than most of them, and he still knows many of his regulars by name.

“A customer is a person, not an order number. Whether they walk into the shop or order from Fujairah, they should get the same respect and the same fair price. That is how I have always worked. A website doesn’t change that.”
— Lalit Kumar

Looking Ahead

Over the coming months, the company plans to add more products, grow its marketplace presence and improve delivery across the UAE.

“I have been building businesses in this country for more than forty years, and I still feel like I’m starting out. As long as I have the energy, I’ll keep going, for my customers, my team and for the UAE.”
— Lalit Kumar

About Natural Spices and Foodstuff Trading LLC

Natural Spices and Foodstuff Trading LLC is a UAE-based grocery and foodstuff company serving customers through its retail outlet, its e-commerce platform NaturalSpicesUAE.com and leading online marketplaces across the United Arab Emirates. The company offers spices, herbs, Indian grocery products, snacks, dry fruits and other food essentials. It is owned and led by Lalit Kumar, who has been in business in the UAE since 1983 across the electronics, transport, oil and gas, and foodstuff sectors.

Media Contact

Organization: Natural Spices and Foodstuff Trading LLC

Contact Person: Lalit Kumar Kundani

Website: https://naturalspicesuae.com/

Email: Send Email

Contact Number: +971529941656

Address: Al Bannai Building, Shop 1, Al Amman Street, Al Nahda 1, Dubai, UAE

City: Dubai

State: Al Nahda 1

Country: United Arab Emirates

Release id: 45332

The post From One Store to 400 Daily Orders: 70-Year-Old Lalit Kumar Takes Natural Spices Online Across UAE appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

file

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

Memito Opens Token Sale on Ethereum With Formula-Based Pricing and Multi-Network Payments

Published

on

Memito, a community meme token on Ethereum, has opened a token sale on memito.org. The price is calculated by a formula in the verified smart contract, and the sale accepts five assets on Ethereum, a bridge from five networks and a wide range of wallets.

Canada, 2nd Oct 2026 – Memito (MEMITO), a community meme token on Ethereum, has opened its public token sale at memito.org, making participation available worldwide in 24 languages, with five payment assets, a built-in bridge from five networks and support for seven popular wallets. The sale is run directly by the token’s smart contract, which is published and verified on Etherscan.

Formula-based pricing set in the contract

Instead of fixed sale rounds, the token price is calculated by a formula written into the smart contract. The formula starts at 0.00000018585 USD per token and adjusts the price according to the total amount raised in the sale. Before confirming a transaction, each participant is shown the calculated quote for the selected amount. Tokens are transferred to the participant’s wallet within the same on-chain transaction, so there is no separate claim step. Trading of the token has not opened, and no date has been set.

Payment options across networks

The sale accepts ETH, USDT, USDC, DAI and WBTC on Ethereum, with individual transactions from about 1 USD to 10,000 USD. For users whose funds are held on BNB Chain, Arbitrum, Base, Polygon or Optimism, the website integrates the third-party LI.FI bridge, which can move funds to ETH on Ethereum and shows the route fees before signing. The website is available in 24 languages.

The sale page supports MetaMask, Trust Wallet, OKX Wallet, Bitget Wallet, Binance Wallet and Bybit Wallet (via WalletConnect), as well as other WalletConnect-compatible wallets, on desktop and mobile devices.

Wallet selection on memito.org
Wallet selection on memito.org

“Memito started as a meme, but we are building it as a community first,” the Memito team said. “We wanted anyone, from any network and in their own language, to be able to join from day one, with the rules of the sale written openly into the contract. The community on X and Telegram is where we share every next step.”

Token details

The token contract address is 0xe02AD79732658a2ec2C85Ecd15De5E08A311373C. Maximum supply is 420,690,000,000,000 MEMITO. When trading opens, the final supply is allocated as follows: 60% to buyers, referrals and the liquidity pool, 10% to a reserve, 15% to the founder share held in the project’s Ecosystem Wallet and 15% to the treasury. The deploying wallet received no tokens at launch.

The memito.org token sale page
The memito.org token sale page

About Memito

Memito (MEMITO) is a community meme token (ERC-20) on Ethereum, distributed through a formula-priced token sale on memito.org. More information is available on the project website and on its X and Telegram channels.

The token sale is open now at memito.org, where participants can review the contract details and the current quote before taking part.

Website: memito.org | X: @MEMITO_COIN | Telegram: t.me/memito_coin

Disclaimer: This press release is provided for information purposes only and is not investment advice. Crypto-assets carry risk, including the loss of funds. Readers should do their own research.

Media Contact

Organization: Memito

Contact Person: Memito Team

Website: https://memito.org

Email: Send Email

Country: Canada

Release id: 49614

The post Memito Opens Token Sale on Ethereum With Formula-Based Pricing and Multi-Network Payments appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

file

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

LATEST POST